Logo image of ASA.OL

ATLANTIC SAPPHIRE ASA (ASA.OL) Stock Fundamental Analysis

OSL:ASA - Euronext Oslo - NO0013464750 - Common Stock - Currency: NOK

7.321  -0.24 (-3.21%)

Fundamental Rating

3

ASA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 56 industry peers in the Food Products industry. Both the profitability and financial health of ASA have multiple concerns. ASA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ASA had negative earnings in the past year.
In the past year ASA has reported a negative cash flow from operations.
In the past 5 years ASA always reported negative net income.
In the past 5 years ASA always reported negative operating cash flow.
ASA.OL Yearly Net Income VS EBIT VS OCF VS FCFASA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M -100M

1.2 Ratios

ASA has a worse Return On Assets (-41.83%) than 92.86% of its industry peers.
Looking at the Return On Equity, with a value of -51.90%, ASA is doing worse than 87.50% of the companies in the same industry.
Industry RankSector Rank
ROA -41.83%
ROE -51.9%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ASA.OL Yearly ROA, ROE, ROICASA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -10 -20 -30 -40 -50

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ASA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASA.OL Yearly Profit, Operating, Gross MarginsASA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 -500 -1K -1.5K -2K

More info and screens

3

2. Health

2.1 Basic Checks

ASA does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for ASA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ASA.OL Yearly Shares OutstandingASA.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
ASA.OL Yearly Total Debt VS Total AssetsASA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -2.60, we must say that ASA is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -2.60, ASA is not doing good in the industry: 91.07% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.15 indicates that ASA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.15, ASA belongs to the top of the industry, outperforming 91.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z -2.6
ROIC/WACCN/A
WACC11.96%
ASA.OL Yearly LT Debt VS Equity VS FCFASA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 1.41 indicates that ASA should not have too much problems paying its short term obligations.
ASA has a Current ratio (1.41) which is in line with its industry peers.
ASA has a Quick Ratio of 1.16. This is a normal value and indicates that ASA is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ASA (1.16) is better than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.16
ASA.OL Yearly Current Assets VS Current LiabilitesASA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for ASA have decreased strongly by -15536.76% in the last year.
Looking at the last year, ASA shows a decrease in Revenue. The Revenue has decreased by -1.16% in the last year.
The Revenue has been growing by 96.31% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-15536.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9167.75%
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y30.69%
Revenue growth 5Y96.31%
Sales Q2Q%38.94%

3.2 Future

ASA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 89.14% yearly.
The Revenue is expected to grow by 22.71% on average over the next years. This is a very strong growth
EPS Next Y-270.21%
EPS Next 2Y61.36%
EPS Next 3Y89.14%
EPS Next 5YN/A
Revenue Next Year102.89%
Revenue Next 2Y86.18%
Revenue Next 3Y77.56%
Revenue Next 5Y22.71%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ASA.OL Yearly Revenue VS EstimatesASA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
ASA.OL Yearly EPS VS EstimatesASA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -100 -200

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ASA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 0.24, the valuation of ASA can be described as very cheap.
ASA's Price/Forward Earnings ratio is rather cheap when compared to the industry. ASA is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ASA to the average of the S&P500 Index (21.38), we can say ASA is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.24
ASA.OL Price Earnings VS Forward Price EarningsASA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASA.OL Per share dataASA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600

4.3 Compensation for Growth

A more expensive valuation may be justified as ASA's earnings are expected to grow with 89.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.36%
EPS Next 3Y89.14%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ASA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATLANTIC SAPPHIRE ASA

OSL:ASA (4/25/2025, 7:00:00 PM)

7.321

-0.24 (-3.21%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)04-23 2025-04-23/amc
Inst Owners1.23%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap262.46M
Analysts40
Price Target627.82 (8475.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)19899.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-22808.2%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)51.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.24
P/S 1.47
P/FCF N/A
P/OCF N/A
P/B 0.1
P/tB 0.1
EV/EBITDA N/A
EPS(TTM)-682.87
EYN/A
EPS(NY)30.59
Fwd EY417.83%
FCF(TTM)-27.06
FCFYN/A
OCF(TTM)-23.56
OCFYN/A
SpS4.97
BVpS76.78
TBVpS76.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.83%
ROE -51.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 82.96%
Cap/Sales 70.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.16
Altman-Z -2.6
F-Score3
WACC11.96%
ROIC/WACCN/A
Cap/Depr(3y)308.07%
Cap/Depr(5y)1123.22%
Cap/Sales(3y)260.86%
Cap/Sales(5y)664.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15536.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9167.75%
EPS Next Y-270.21%
EPS Next 2Y61.36%
EPS Next 3Y89.14%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y30.69%
Revenue growth 5Y96.31%
Sales Q2Q%38.94%
Revenue Next Year102.89%
Revenue Next 2Y86.18%
Revenue Next 3Y77.56%
Revenue Next 5Y22.71%
EBIT growth 1Y-2.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.66%
EBIT Next 3Y57.27%
EBIT Next 5Y25.94%
FCF growth 1Y14.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-104.37%
OCF growth 3YN/A
OCF growth 5YN/A